This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hubert Truebel: Innovator in Medicinal Chemistry
Introduction
Hubert Truebel is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of new pharmaceutical compounds.
Latest Patents
Truebel holds a patent for "Substituted benzyl and phenylsulfonyl triazolones, and use thereof." This patent relates to new, substituted benzyl-1,2,4-triazolones and phenylsulfonyl-1,2,4-triazolones. The application details processes for preparing these compounds and their use in treating and preventing diseases, especially cardiovascular disorders. He has 1 patent to his name.
Career Highlights
Truebel is associated with Bayer Intellectual Property GmbH, where he has been involved in innovative research and development. His work focuses on creating effective medicaments for various health conditions.
Collaborations
Throughout his career, Truebel has collaborated with esteemed colleagues such as Ulf Brüggemeier and Ingo Flamme. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical solutions.
Conclusion
Hubert Truebel's work in medicinal chemistry exemplifies the impact of innovation in healthcare. His contributions continue to pave the way for advancements in the treatment of cardiovascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile